For in vivo studies, AD pathology-specific parameters like protein level of amyloid precursor protein, β-amyloid and phosphorylated-Tau at T-231 and AChE activity were estimated, and all the parameters were increased in STZ-induced AD model (Fig. S2a–e). Here, MAPT is linked to Alzheimer disease.